Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Upgrades

• Morgan Stanley upgraded the previous rating for Pure Storage Inc PSTG from Equal-Weight to Overweight. In the second quarter, Pure Storage showed an EPS of $0.32, compared to $0.14 from the year-ago quarter. The current stock performance of Pure Storage shows a 52-week-high of $36.71 and a 52-week-low of $21.89. Moreover, at the end of the last trading period, the closing price was at $30.50.
• According to Oppenheimer, the prior rating for Biomarin Pharmaceutical Inc BMRN was changed from Perform to Outperform. In the third quarter, Biomarin Pharmaceutical showed an EPS of $0.04, compared to $0.20 from the year-ago quarter. The current stock performance of Biomarin Pharmaceutical shows a 52-week-high of $97.76 and a 52-week-low of $70.73. Moreover, at the end of the last trading period, the closing price was at $86.77.
• Barclays upgraded the previous rating for Intel Corp INTC from Underweight to Equal-Weight. For the third quarter, Intel had an EPS of $0.59, compared to year-ago quarter EPS of $1.71. The current stock performance of Intel shows a 52-week-high of $56.28 and a 52-week-low of $24.59. Moreover, at the end of the last trading period, the closing price was at $29.07.
• According to Barclays, the prior rating for Gilead Sciences Inc GILD was changed from Underweight to Equal-Weight. In the third quarter, Gilead Sciences showed an EPS of $1.90, compared to $2.65 from the year-ago quarter. The stock has a 52-week-high of $79.61 and a 52-week-low of $57.16. At the end of the last trading period, Gilead Sciences closed at $79.27.
• JP Morgan upgraded the previous rating for TrueCar Inc TRUE from Underweight to Overweight. TrueCar earned $0.12 in the second quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.08 and a 52-week-low of $1.30. TrueCar closed at $1.52 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

• Oppenheimer downgraded the previous rating for Ayala Pharmaceuticals Inc AYLA from Outperform to Perform. Ayala Pharmaceuticals earned $0.54 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of Ayala Pharmaceuticals shows a 52-week-high of $9.40 and a 52-week-low of $0.57. Moreover, at the end of the last trading period, the closing price was at $0.69.
• Roth Capital downgraded the previous rating for Argo Blockchain PLC ARBK from Neutral to Sell. Argo Blockchain earned $0.82 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.14 and a 52-week-low of $1.37. Argo Blockchain closed at $1.97 at the end of the last trading period.
• According to Raymond James, the prior rating for Aon PLC AON was changed from Market Perform to Underperform. Aon earned $2.02 in the third quarter, compared to $1.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $341.98 and a 52-week-low of $246.21. Aon closed at $289.20 at the end of the last trading period.
• According to Wells Fargo, the prior rating for Hanesbrands Inc HBI was changed from Overweight to Underweight. In the second quarter, Hanesbrands showed an EPS of $0.28, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $17.55 and a 52-week-low of $6.91. Hanesbrands closed at $7.20 at the end of the last trading period.
• According to Wedbush, the prior rating for Y-mAbs Therapeutics Inc YMAB was changed from Outperform to Neutral. For the second quarter, Y-mAbs Therapeutics had an EPS of $0.94, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $20.48 and a 52-week-low of $6.50. Y-mAbs Therapeutics closed at $8.93 at the end of the last trading period.
• For Advanced Micro Devices Inc AMD, Northland Capital Markets downgraded the previous rating of Outperform to Market Perform. For the second quarter, Advanced Micro Devices had an EPS of $1.05, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $152.42 and a 52-week-low of $54.57. At the end of the last trading period, Advanced Micro Devices closed at $62.01.
• For Cedar Fair LP FUN, Credit Suisse downgraded the previous rating of Outperform to Neutral. Cedar Fair earned $0.89 in the second quarter, compared to $1.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $62.56 and a 52-week-low of $37.78. Cedar Fair closed at $41.00 at the end of the last trading period.
• According to Barclays, the prior rating for Amgen Inc AMGN was changed from Equal-Weight to Underweight. For the second quarter, Amgen had an EPS of $4.65, compared to year-ago quarter EPS of $4.38. The stock has a 52-week-high of $274.54 and a 52-week-low of $214.39. At the end of the last trading period, Amgen closed at $273.81.
• Barclays downgraded the previous rating for LyondellBasell Industries NV LYB from Overweight to Equal-Weight. In the third quarter, LyondellBasell Industries showed an EPS of $1.96, compared to $5.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $117.22 and a 52-week-low of $71.46. LyondellBasell Industries closed at $77.99 at the end of the last trading period.
• For Texas Roadhouse Inc TXRH, Deutsche Bank downgraded the previous rating of Buy to Hold. Texas Roadhouse earned $0.93 in the third quarter, compared to $0.75 in the year-ago quarter. At the moment, the stock has a 52-week-high of $100.37 and a 52-week-low of $68.58. Texas Roadhouse closed at $98.71 at the end of the last trading period.
• For Honeywell International Inc HON, Daiwa Capital downgraded the previous rating of Outperform to Neutral. Honeywell Intl earned $2.25 in the third quarter, compared to $2.02 in the year-ago quarter. The current stock performance of Honeywell Intl shows a 52-week-high of $221.89 and a 52-week-low of $166.63. Moreover, at the end of the last trading period, the closing price was at $204.93.
• For Keurig Dr Pepper Inc KDP, Truist Securities downgraded the previous rating of Hold to Sell. For the third quarter, Keurig Dr Pepper had an EPS of $0.46, compared to year-ago quarter EPS of $0.44. The current stock performance of Keurig Dr Pepper shows a 52-week-high of $41.31 and a 52-week-low of $33.35. Moreover, at the end of the last trading period, the closing price was at $39.55.
• UBS downgraded the previous rating for Caterpillar Inc CAT from Buy to Neutral. For the third quarter, Caterpillar had an EPS of $3.95, compared to year-ago quarter EPS of $2.66. The stock has a 52-week-high of $237.90 and a 52-week-low of $160.60. At the end of the last trading period, Caterpillar closed at $219.34.
• For DaVita Inc DVA, UBS downgraded the previous rating of Buy to Neutral. For the third quarter, DaVita had an EPS of $1.45, compared to year-ago quarter EPS of $2.36. At the moment, the stock has a 52-week-high of $124.81 and a 52-week-low of $69.26. DaVita closed at $70.54 at the end of the last trading period.
• For Paramount Global PARA, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the second quarter, Paramount Global showed an EPS of $0.64, compared to $0.97 from the year-ago quarter. The current stock performance of Paramount Global shows a 52-week-high of $39.21 and a 52-week-low of $17.93. Moreover, at the end of the last trading period, the closing price was at $19.02.
• JP Morgan downgraded the previous rating for Reinsurance Group of America Inc RGA from Overweight to Neutral. For the second quarter, Reinsurance Group had an EPS of $5.78, compared to year-ago quarter EPS of $4.00. At the moment, the stock has a 52-week-high of $148.75 and a 52-week-low of $97.61. Reinsurance Group closed at $148.55 at the end of the last trading period.
• BMO Capital downgraded the previous rating for Sonoco Products Co SON from Market Perform to Underperform. In the second quarter, Sonoco Products showed an EPS of $1.76, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $67.06 and a 52-week-low of $51.52. At the end of the last trading period, Sonoco Products closed at $64.86.
• For Greif Inc GEF, BMO Capital downgraded the previous rating of Market Perform to Underperform. For the third quarter, Greif had an EPS of $2.35, compared to year-ago quarter EPS of $1.93. The stock has a 52-week-high of $72.80 and a 52-week-low of $53.65. At the end of the last trading period, Greif closed at $69.05.

See all analyst ratings downgrades.

Initiations

• Guggenheim initiated coverage on Iovance Biotherapeutics Inc IOVA with a Neutral rating. Iovance Biotherapeutics earned $0.63 in the second quarter, compared to $0.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.66 and a 52-week-low of $6.18. Iovance Biotherapeutics closed at $9.75 at the end of the last trading period.
• With a Buy rating, Guggenheim initiated coverage on Century Therapeutics Inc IPSC. The price target seems to have been set at $15.00 for Century Therapeutics. For the second quarter, Century Therapeutics had an EPS of $0.54, compared to year-ago quarter EPS of $1.93. The current stock performance of Century Therapeutics shows a 52-week-high of $16.83 and a 52-week-low of $7.32. Moreover, at the end of the last trading period, the closing price was at $10.78.
• With a Buy rating, Guggenheim initiated coverage on Arcellx Inc ACLX. The price target seems to have been set at $36.00 for Arcellx. For the second quarter, Arcellx had an EPS of $0.88, compared to year-ago quarter EPS of $36.42. The current stock performance of Arcellx shows a 52-week-high of $26.91 and a 52-week-low of $6.04. Moreover, at the end of the last trading period, the closing price was at $22.01.
• For Solid Power Inc SLDP, Cowen & Co. initiated coverage, by setting the current rating at Market Perform. For the second quarter, Solid Power had an EPS of $0.08, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $9.99 and a 52-week-low of $4.58. At the end of the last trading period, Solid Power closed at $5.55.
• Cowen & Co. initiated coverage on FREYR Battery FREY with an Outperform rating. For the second quarter, FREYR Battery had an EPS of $0.24, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $16.94 and a 52-week-low of $6.42. FREYR Battery closed at $13.02 at the end of the last trading period.
• BTIG initiated coverage on PROCEPT BioRobotics Corp PRCT with a Neutral rating. PROCEPT BioRobotics earned $0.43 in the second quarter, compared to $2.60 in the year-ago quarter. The current stock performance of PROCEPT BioRobotics shows a 52-week-high of $52.40 and a 52-week-low of $15.38. Moreover, at the end of the last trading period, the closing price was at $45.34.
• BTIG initiated coverage on Outlook Therapeutics Inc OTLK with a Buy rating. The price target for Outlook Therapeutics is set to $7.00. Outlook Therapeutics earned $0.08 in the third quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.12 and a 52-week-low of $0.68. Outlook Therapeutics closed at $1.20 at the end of the last trading period.
• Jefferies initiated coverage on NetApp Inc NTAP with a Buy rating. The price target for NetApp is set to $88.00. NetApp earned $1.20 in the first quarter, compared to $1.15 in the year-ago quarter. The stock has a 52-week-high of $96.82 and a 52-week-low of $60.56. At the end of the last trading period, NetApp closed at $69.40.
• With a Equal-Weight rating, Wells Fargo initiated coverage on Veeva Systems Inc VEEV. The price target seems to have been set at $180.00 for Veeva Sys. For the second quarter, Veeva Sys had an EPS of $1.03, compared to year-ago quarter EPS of $0.94. The current stock performance of Veeva Sys shows a 52-week-high of $257.68 and a 52-week-low of $151.02. Moreover, at the end of the last trading period, the closing price was at $171.58.
• With an Overweight rating, Wells Fargo initiated coverage on Doximity Inc DOCS. The price target seems to have been set at $38.00 for Doximity. In the first quarter, Doximity showed an EPS of $0.14, compared to $0.11 from the year-ago quarter. The current stock performance of Doximity shows a 52-week-high of $64.95 and a 52-week-low of $23.73. Moreover, at the end of the last trading period, the closing price was at $26.31.
• Guggenheim initiated coverage on 2seventy bio Inc TSVT with a Buy rating. The price target for 2seventy bio is set to $30.00. 2seventy bio earned $2.02 in the second quarter, compared to $3.60 in the year-ago quarter. The current stock performance of 2seventy bio shows a 52-week-high of $27.04 and a 52-week-low of $9.91. Moreover, at the end of the last trading period, the closing price was at $15.24.
• With a Hold rating, Jefferies initiated coverage on Dell Technologies Inc DELL. The price target seems to have been set at $39.00 for Dell Technologies. Dell Technologies earned $1.68 in the second quarter, compared to $2.24 in the year-ago quarter. The stock has a 52-week-high of $61.54 and a 52-week-low of $32.90. At the end of the last trading period, Dell Technologies closed at $39.16.
• Keybanc initiated coverage on Bumble Inc BMBL with a Sector Weight rating. Bumble earned $0.03 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.33 and a 52-week-low of $15.41. Bumble closed at $25.50 at the end of the last trading period.
• With an Overweight rating, Piper Sandler initiated coverage on Gritstone Bio Inc GRTS. The price target seems to have been set at $6.00 for Gritstone Bio. Gritstone Bio earned $0.34 in the second quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $13.01 and a 52-week-low of $1.71. At the end of the last trading period, Gritstone Bio closed at $2.71.

See all analyst ratings initiations.